The All-Russia GMP Conference has been held since 2016 and annually brings together leading international and Russian experts in the pharmaceutical industry, government representatives, managers and specialists of pharmaceutical companies, representatives of professional associations and communities, experts in the field of Quality Management System and Good Manufacturing Practice (GMP).
The Conference is organized by the Ministry of Industry and Trade of the Russian Federation together with the «State Institute of Drugs and Good Practices».
Over the past years, representatives of the world pharmaceutical community from Russia, the USA, Austria, Spain, Croatia, Japan, Switzerland, Italy, Poland, Hungary, Romania, Mexico, the Great Britain, Cuba, Bulgaria, Kazakhstan, Kyrgyzstan, Germany, Brazil, Slovenia and other countries took part in the Conference.
Partners of the Conference are the largest Russian and international companies, leading industry publishers and professional communities.
Each year, the event takes place in a new region of Russia, which helps the organizers to demonstrate the best practices in various parts of the country, and the participants to get acquainted with the regional aspect of the organization of the healthcare system and medicines supply.
For the fifth year now, the All-Russia GMP Conference has been actively partnering the leading mass media specialising in pharmaceutics, medicine, and GMP practices.
On Saturday we place our focus on Roszdravnadzor’s new recommendations regarding the use of the MDLP system by the pharmaceutical industry. The document which offers clarifications on six cases that are the most typical for entities participating in the circulation of drugs involving labelled and non-labelled drugs was published on September 10 this year.
This is the name of the topic to be discussed at the Vth All-Russia GMP Conference at the panel discussion on the “Potential of Local API Manufacturing and Current Local Manufacturing Practices”, which is sponsored by Pharmasyntez.
One of the most-attended sessions at GMP Conference 2019 was “The Certification of Conformity to GMP in the Context of Transition Towards a Common Market”.
For the autumn and winter season of 2020-2021, the federal budget allocated RUB 22.5 bln for the procurement of vaccines. However, last week, on September 11, Prime Minister of the Russian Federation Mikhail Mishustin signed Decree No. 2314-r to allocate an extra amount of RUB 4.1 bln. for the procurement of vaccines.